Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NORTHERN TRUST CORPORATION

(NTRS)
  Report
Delayed Nasdaq  -  04:00 2022-09-29 pm EDT
86.27 USD   -1.33%
09/27Northern Trust Integrated Trading Solutions Recognized as Leader in Chartis Research Outsourced Trading Solutions Report, 2022
BU
09/27Deutsche Bank Adjusts Northern Trust's Price Target to $120 From $123, Maintains Buy Rating
MT
09/22Northern Trust Appoints Stephanie H. Giroux Senior Portfolio Advisor in New York Market
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Queen's University Belfast : Queen's University part of new research initiative to help prevent psychosis in young people

06/23/2022 | 06:29am EDT

Queen's University is part of a new research initiative which will train PhD students with the aim of identifying and preventing psychosis in young people.

The Psychosis Ireland Structured Training and Research Programme (PSI-STAR) is a cross-disciplinary PhD research training programme. It will be led by an All-Ireland team of clinicians and academics from the fields of psychiatry, nursing, social work, sociology and psychology, and importantly includes an academic with lived experience of psychosis.

The programme will train five PhD students who will go on to be leaders in the field of psychosis and make a positive impact on people's lives.

The Queen's project leads are Dr Ciaran Mulholland, Consultant Psychiatrist at Queen's and the Impact Research Centre in the Northern Trust; Dr Ciaran Shannon, Consultant Clinical Psychologist at Queen's and Director of the Impact Research Centre in the Northern Trust; and Gavin Davidson, Professor of Social Care at Queen's and Praxis Chair of Social Care.

Psychotic disorders, such as schizophrenia and bipolar disorder, occur in about three in one hundred people and usually starts in adolescence or young adulthood, greatly disrupting a young person's life in terms of education, social relationships and career outcomes. Because of the early age of onset and chronicity, these disorders have a devastating impact on young people and families.

The NI Youth Mental Health Study demonstrates that almost 19% of young people aged 11-19 years reported psychotic-like experiences, which suggests an increased risk of developing a psychotic illness such as schizophrenia. Only a small proportion of these individuals will develop a psychotic illness, and the PSI-STAR research programme is designed to both improve the ability to predict who will do so, and the ability to intervene early in the illness course to improve outcomes.

Dr Ciaran Mulholland, the Principal Investigator at Queen's, explains: 'It is important to identify young people in the early stages of psychosis (or even just before it begins) so that the best treatment and support can be offered without delay. This will greatly improve the chances of recovery and better long-term outcomes.

'We can do this by identifying young people who are at risk as well as predicting young people who may be at a greater risk of developing psychosis. Our collaborative Doctoral Award Programme - PSI-STAR - will address these issues.'

The research project based at Queen's will be a participatory action project, which will involve researchers and participants working together to co-design and trial school-based intervention measures focused on distress associated with psychotic symptoms in young people.

The project is funded by the Health Research Board and the partnership includes Queen's University Belfast, Royal College of Surgeons Ireland, the Impact Research Centre in the Northern Health and Social Care Trust, NUI Galway, Trinity College Dublin, University College Cork and University College Dublin.

The funded PhD projects will start in October 2022 and will be conducted over four years. Applicants can now apply for this opportunity here with a closing date of 8 July. More information is available on the PSI-STAR website at https://psistarstudy.eu/

For further information about PSI-STAR and the project at Queen's please contact Dr Ciaran Mulholland, email c.c.mulholland@qub.ac.uk

(C) 2022 Electronic News Publishing, source ENP Newswire

All news about NORTHERN TRUST CORPORATION
09/27Northern Trust Integrated Trading Solutions Recognized as Leader in Chartis Research Ou..
BU
09/27Deutsche Bank Adjusts Northern Trust's Price Target to $120 From $123, Maintains Buy Ra..
MT
09/22Northern Trust Appoints Stephanie H. Giroux Senior Portfolio Advisor in New York Market
BU
09/21Northern Trust Raises Prime Rate
BU
09/21Northern Trust Creates New Leadership Role within Digital Assets and Financial Markets ..
BU
09/21Northern Trust Appoints Michael Buzza as Global Head of Network Management & Market Str..
CI
09/21Bank of England-Minutes of the London FXJSC Operations Sub-Committee Meeting - 7 June 2..
AQ
09/21Northern Trust : Creates New Leadership Role within Digital Assets and Financial Markets G..
PU
09/20Northern Trust Corporation to Webcast Third Quarter 2022 Earnings Conference Call
BU
09/12Transcript : Northern Trust Corporation Presents at Barclays Global Financial..
CI
More news
Analyst Recommendations on NORTHERN TRUST CORPORATION
More recommendations
Financials (USD)
Sales 2022 7 086 M - -
Net income 2022 1 573 M - -
Net Debt 2022 10 698 M - -
P/E ratio 2022 11,6x
Yield 2022 3,33%
Capitalization 18 219 M 18 219 M -
EV / Sales 2022 4,08x
EV / Sales 2023 3,99x
Nbr of Employees 21 100
Free-Float 84,6%
Chart NORTHERN TRUST CORPORATION
Duration : Period :
Northern Trust Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NORTHERN TRUST CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 87,43 $
Average target price 112,94 $
Spread / Average Target 29,2%
EPS Revisions
Managers and Directors
Michael G. O'Grady Chairman, President & Chief Executive Officer
Jason J. Tyler Chief Financial Officer & Executive Vice President
Thomas A. South Chief Information Officer & Executive VP
Angelo G. Manioudakis Chief Investment Officer
Susan M. Crown Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NORTHERN TRUST CORPORATION-26.90%18 219
BLACKROCK, INC.-36.06%88 265
BROOKFIELD ASSET MANAGEMENT INC.-24.51%65 912
UBS GROUP AG-10.93%48 615
BANK OF NEW YORK MELLON CORPORATION (THE)-31.84%31 993
APOLLO GLOBAL MANAGEMENT, INC.-31.52%28 652